Governance Genmab A/S

GMAB

DK0010272202

Biotechnology & Medical Research

Real-time Estimate Cboe Europe Other stock markets 10:16:34 15/01/2025 GMT			5-day change	1st Jan Change
1,509.50 ^DKK	-4.16%		-5.19%	+1.61%

12:00am	Genmab A/S Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-14-2025 03:00 PM
01-02	A poor 2024 increases the odds of a brighter 2025

Executive Committee: Genmab A/S

Manager

Positions heldSince

Jan van de Winkel

64 year

Chief Executive Officer	31/05/2010
Founder	31/12/1998
President	31/05/2010

Birgitte Stephensen

64 year

General Counsel

Christopher Cozic

47 year

Human Resources Officer

Tahamtan Ahmadi

52 year

Chief Tech/Sci/R&D Officer

31/01/2021

Andrew Carlsen

Investor Relations Contact

Anthony Pagano

47 year

Director of Finance/CFO

29/02/2020

Rayne Waller

Chief Tech/Sci/R&D Officer

15/08/2024

Composition of the Board of Directors: Genmab A/S

Director

CommitteesSince

Deirdre Connelly

64 year

Compensation Committee	25/03/2020
Governance Committee Chair	25/03/2020
Nominating Committee Chair	25/03/2020
Audit Committee	25/03/2020
Executive Committee
Finance Committee	25/03/2020

Anders Gersel Pedersen

74 year

Audit Committee	31/12/2019
Finance Committee	31/12/2013
Governance Committee	31/10/2003
Nominating Committee	31/10/2003
Compensation Committee Chair	31/12/2019
Compensation Committee	28/05/2018
Nominating Committee Chair	31/12/2019

Elizabeth O'Farrell

60 year

Audit Committee	28/03/2022
Compensation Committee Chair	31/12/2019
Audit Committee Chair	31/01/2021
Finance Committee	28/03/2022
Compensation Committee	28/03/2022

Pernille Erenbjerg

58 year

Governance Committee	31/12/2014
Nominating Committee	31/12/2014
Audit Committee Chair	26/04/2022
Finance Committee Chair	31/12/2014

Rolf K. Hoffmann

64 year

Audit Committee	31/12/2015
Finance Committee	31/12/2015
Compensation Committee	14/06/2023
Nominating Committee	14/06/2023

Paolo Augusto Paoletti

74 year

Compensation Committee

Mijke Zachariasse

52 year

Director/Board Member

28/03/2019

Martin Schultz

50 year

Director/Board Member

31/12/2021

Takahiro Hamatani

51 year

Director/Board Member

31/12/2021

Latest Appointments: Genmab A/S

Aadi Bioscience, Inc. Appoints Baiteng Zhao to its Board of Directors	12-19	CI
HOOKIPA Pharma Names Julie O'Neill Nonexecutive Chair	30/08/24	MT
Genmab Names First Chief Technology, Chief Commercial Officers; COO to Exit	16/08/24	MT
Genmab COO Anthony Mancini Departs; Firm Names New CTO, CCO	16/08/24	MT
Genmab Operations Chief Anthony Mancini Departing	16/08/24	MT
Genmab A/S Announces Executive Changes	16/08/24	CI
Genmab A/S Announces Executive Changes	13/03/24	CI

More news

Former Officers and Directors: Genmab A/S

Insider

Positions held

SinceUntil

Anthony Mancini

Chief Operating Officer

22/03/2020

15/08/2024

Jonathan Peacock

Director/Board Member	25/03/2020	14/11/2021
Independent Dir/Board Member	25/03/2020	14/11/2021

Suba Krishnan

Corporate Officer/Principal

31/08/2019

31/10/2020

Michael K. Bauer

Chief Tech/Sci/R&D Officer	-	30/09/2020
Corporate Officer/Principal	31/07/2012	-

Mats Gunnar Pettersson

Director/Board Member	16/04/2013	-
Chairman	16/04/2013	25/03/2020
Independent Dir/Board Member	16/04/2013	25/03/2020

David Andrew Eatwell

Director of Finance/CFO

01/06/2008

28/02/2020

Richard Gordon Hibbert

Director/Board Member

31/12/2015

28/03/2019

Rachel Curtis Gravesen

Investor Relations Contact	30/04/2011	10/03/2019
Public Communications Contact	30/04/2011	10/03/2019

Rima Bawarsh Nassar

Director/Board Member

31/12/2018

Burt Malkiel

Director/Board Member	31/03/2010	31/05/2018
Independent Dir/Board Member	31/12/2006	31/05/2018

Paul W. H. I. Parren

Chief Tech/Sci/R&D Officer

31/08/2001

31/07/2017

Steen Lisby

Chief Tech/Sci/R&D Officer

31/12/2007

31/12/2016

Peter Storm Kristensen

Director/Board Member

31/12/2015

Hans Henrik Munch-Jensen

Director/Board Member	25/03/2009	31/12/2014
Independent Dir/Board Member	31/12/2006	31/12/2014

Daniel John Bruno

Comptroller/Controller/Auditor	31/12/2007	31/03/2013
Director/Board Member	24/06/2010	31/03/2013
Comptroller/Controller/Auditor	31/12/2015	-
Director/Board Member	31/12/2015	31/07/2020

Antonius Theodorus M Wilderbeek

Director/Board Member	05/04/2011	31/03/2013
Independent Dir/Board Member	05/04/2011	31/03/2013

Michael Blair Widmer

Director/Board Member	27/03/2012	31/03/2013
Chairman	28/02/2002	26/04/2012
Independent Dir/Board Member	28/02/2002	31/03/2013

Karsten Havkrog Pedersen

Director/Board Member	28/02/2002	31/03/2013
Independent Dir/Board Member	28/02/2002	31/03/2013

Patrick van Berkel

Chief Tech/Sci/R&D Officer

31/12/2002

31/12/2011

Helle Husted

Investor Relations Contact	27/04/2011	30/04/2011
Public Communications Contact	-	27/04/2011

Joris Wilms

Corporate Officer/Principal

30/09/2008

30/11/2010

Eva Ehrnrooth

Chief Tech/Sci/R&D Officer

31/05/2008

31/01/2010

Lisa N. Drakeman

Founder	31/12/1998	31/12/2009
President	31/12/1998	31/12/2009

Ernst H. Schweizer

Director/Board Member

25/03/2009

14/04/2009

Barry Littlejohns

Chief Operating Officer

27/05/2010

Bo Kruse

Comptroller/Controller/Auditor	31/12/1999	31/12/2004
Director of Finance/CFO	31/12/2004	01/06/2008

Claus Juan Møller-San Pedro

Chief Operating Officer

31/12/1998

31/12/2007

Irwin Lerner

Director/Board Member

30/01/2007

Hanne Jensen

Corporate Officer/Principal

31/12/1998

Christina Hahner

Chief Administrative Officer	31/12/2004	-
Public Communications Contact	31/12/2004	-

Annarie Lyles

Corporate Officer/Principal

27/05/2010

Joseph Fred Yospe

Comptroller/Controller/Auditor

31/08/2002

31/08/2004

Nedjad Losic

Director/Board Member	24/06/2010	-
Corporate Officer/Principal	31/12/2003	-

Michael Wolff Jensen

Director of Finance/CFO

31/12/1999

31/12/2002

Tom Vink

Director/Board Member	24/06/2010	-
Corporate Officer/Principal	31/12/2001	-

Jorgen Petersen

Chief Tech/Sci/R&D Officer

31/12/2001

Rikke Glahn Ren

Corporate Officer/Principal

31/12/2000

Ole Baadsgaard

Chief Tech/Sci/R&D Officer	27/05/2010	-
Corporate Officer/Principal	27/05/2010	27/05/2010

Florian Schönharting

Founder

31/12/1998

Donald Lee Drakeman

Founder

31/12/1998

Eva Steiness

Chairman

Flemming Heise Pedersen

Director/Board Member

Francesco de Rubertis

Director/Board Member

Torben Lund-Hansen

Corporate Officer/Principal

Dorrit T. Andersen

General Counsel

Linda Basse

Chief Tech/Sci/R&D Officer

Jesper Zeuthen

Chairman

Age distribution of managers

Parity Men Women

Male	14
Female	5

Of which Executive Committee

Male	6
Female	1

Of which Directors

Male	6
Female	3

ESG MSCI

ESG

Environment

Social

Governance

Controversy

Genmab A/S specializes in the research and development of human and therapeutic antibodies intended for treating cancers, infectious diseases, rheumatoid arthritis, etc. Net sales break down by type of income as follows: - royalties (83.2%); - income from research and development (12.4%); - other (4.4%): primarily income from partnership agreement. At the end of 2023, the group had a portfolio of more than 20 products in clinical development phase and 20 in preclinical development phase. Denmark accounts for all net sales.

Employees

2,635

Sector

Biotechnology & Medical Research

Calendar

14/01/2025 - JP Morgan Healthcare Conference

More about the company